Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.
đ Full Story

I Keep Buying This Stock (I Bought More Today)
- EXCLUSIVE: Trump Admin Has Major Questions For Blue City Singling Out âBIPOCâ People For Housing Funds - Hudson Crozier
- Current Mortgage Rates: September 19, 2025
- Elon Musk's Ambitious Plan: To Send One Million Humans to Mars within the Next Decade - Michael A. Medeiros
- CDC spiraled into chaos this week. Hereâs where things stand. - Beth Mole
- The Evolution and Impact of Internet Jokes: A Closer Look at Prank.Chat - Bertha Stephens
- The Full Moons of 2024: A Comprehensive Guide to Their Names and Dates - Arya Chandran

Serial Squatter wonât vacate without back rent she never paid
- Jimmy Kimmel - Tom Stiglich
- Transgenderism vs. âTrans Ideologyâ: A Useful Distinction, No Matter What the Activist Class Says - Noah Rothman
- 8 Vegetables To Boost Your Vitamin C Intake - Merve Ceylan
- Thursday's Final Word
- iOS 18 Elevates the iPhone with Unmatched Personalization and Intelligence - Michael A. Medeiros
- Raunchy Robert Downey Jr. Movie On Netflix Is Your New Problematic Fave - Chris Snellgrove